Non-alcoholic Fatty Liver Disease in Patients with Morbid Obesity: the Gut Microbiota Axis As a Potential Pathophysiology Mechanism

Overview

Journal J Gastroenterol

Specialty Gastroenterology

Date 2024 Jan 24

PMID 38265508

Authors

Isabel Cornejo-Pareja

Mohamed Reda Amiar

Luis Ocana-Wilhelmi

Rocio Soler-Humanes

Isabel Arranz-Salas

Lourdes Garrido-Sanchez

Carolina Gutierrez-Repiso

Francisco Jose Tinahones

Affiliations

Soon will be listed here.

Abstract

Background/aim: Alterations in gut microbiota are associated with the pathogenesis of metabolic diseases, including metabolic-associated fatty liver disease (MAFLD). The aim of this study was to evaluate gut microbiota composition and functionality in patients with morbid obesity with different degrees of MAFLD, as assessed by biopsy.

Subjects/methods: 110 patients with morbid obesity were evaluated by biopsy obtained during bariatric surgery for MAFLD. Stool samples were collected prior to surgery for microbiota analysis.

Results: Gut microbiota from patients with steatosis and non-alcoholic steatohepatitis (NASH) were characterized by an enrichment in Enterobacteriaceae (an ethanol-producing bacteria), Acidaminococcus and Megasphaera and the depletion of Eggerthellaceae and Ruminococcaceae (SCFA-producing bacteria). MAFLD was also associated with enrichment of pathways related to proteinogenic amino acid degradation, succinate production, menaquinol-7 (K2-vitamin) biosynthesis, and saccharolytic and proteolytic fermentation. Basic histological hepatic alterations (steatosis, necroinflammatory activity, or fibrosis) were associated with specific changes in microbiota patterns. Overall, the core microbiome related to basic histological alterations in MAFLD showed an increase in Enterobacteriaceae and a decrease in Ruminococcaceae. Specifically, Escherichia coli was associated with steatosis and necroinflammatory activity, whilst Escherichia-shigella was associated with fibrosis and necroinflammatory activity.

Conclusions: We established a link between gut microbiota alterations and histological injury in liver diagnosis using biopsy. Harmful products such as ethanol or succinate may be involved in the pathogenesis and progression of MAFLD. Thus, these alterations in gut microbiota patterns and their possible metabolic pathways could add information to the classical predictors of MAFLD severity and suggest novel metabolic targets.

Citing Articles

Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom.

Sakane S, Hikita H J Gastroenterol. 2025; 60(3):389-391.

PMID: 39847088 DOI: 10.1007/s00535-025-02214-2.

Deep sequencing-derived Metagenome Assembled Genomes from the gut microbiome of liver transplant patients.

Banerjee G, Papri S, Huang H, Satapathy S, Banerjee P Sci Data. 2025; 12(1):39.

PMID: 39788961 PMC: 11717916. DOI: 10.1038/s41597-024-04153-8.

Characterization of the hepatic flora and metabolome in nonalcoholic fatty liver disease.

Jiang H, Wang H, Guo Y, Zhu Y, Dai H, Liang C Front Microbiol. 2025; 15:1528258.

PMID: 39760085 PMC: 11697427. DOI: 10.3389/fmicb.2024.1528258.

Gut-Microbiota-Derived Butyric Acid Overload Contributes to Ileal Mucosal Barrier Damage in Late Phase of Chronic Unpredictable Mild Stress Mice.

Wang C, Qiu M, Wang S, Luo J, Huang L, Deng Q Int J Mol Sci. 2024; 25(23).

PMID: 39684708 PMC: 11641654. DOI: 10.3390/ijms252312998.

Weight Loss After Sleeve Gastrectomy According to Metabolic Dysfunction-Associated Steatotic Liver Disease Stage in Patients with Obesity: A Liver Biopsy-Based Prospective Study.

Martinez-Montoro J, Arranz-Salas I, Gutierrez-Repiso C, Sanchez-Garcia A, Ocana-Wilhelmi L, Pinazo-Bandera J Nutrients. 2024; 16(22).

PMID: 39599643 PMC: 11597773. DOI: 10.3390/nu16223857.

References

Williams C, Stengel J, Asike M, Torres D, Shaw J, Contreras M . Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2010; 140(1):124-31. DOI: 10.1053/j.gastro.2010.09.038. View

Donnelly K, Smith C, Schwarzenberg S, Jessurun J, Boldt M, Parks E . Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005; 115(5):1343-51. PMC: 1087172. DOI: 10.1172/JCI23621. View

Sheka A, Adeyi O, Thompson J, Hameed B, Crawford P, Ikramuddin S . Nonalcoholic Steatohepatitis: A Review. JAMA. 2020; 323(12):1175-1183. DOI: 10.1001/jama.2020.2298. View

Eslam M, Newsome P, Sarin S, Anstee Q, Targher G, Romero-Gomez M . A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020; 73(1):202-209. DOI: 10.1016/j.jhep.2020.03.039. View

Polyzos S, Kountouras J, Mantzoros C . Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2018; 92:82-97. DOI: 10.1016/j.metabol.2018.11.014. View

Aguirre M, Venema K . The art of targeting gut microbiota for tackling human obesity. Genes Nutr. 2015; 10(4):472. PMC: 4437988. DOI: 10.1007/s12263-015-0472-4. View

Bajaj J, Heuman D, Hylemon P, Sanyal A, White M, Monteith P . Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol. 2013; 60(5):940-7. PMC: 3995845. DOI: 10.1016/j.jhep.2013.12.019. View

Chavez-Talavera O, Tailleux A, Lefebvre P, Staels B . Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. Gastroenterology. 2017; 152(7):1679-1694.e3. DOI: 10.1053/j.gastro.2017.01.055. View

Li F, Ye J, Shao C, Zhong B . Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis. Lipids Health Dis. 2021; 20(1):22. PMC: 7908766. DOI: 10.1186/s12944-021-01440-w. View

10.

Brandl K, Schnabl B . Intestinal microbiota and nonalcoholic steatohepatitis. Curr Opin Gastroenterol. 2017; 33(3):128-133. PMC: 5662009. DOI: 10.1097/MOG.0000000000000349. View

11.

Adams L, George J, Bugianesi E, Rossi E, de Boer W, van der Poorten D . Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2011; 26(10):1536-43. DOI: 10.1111/j.1440-1746.2011.06774.x. View

12.

Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough A . Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol. 2009; 51(6):1061-7. PMC: 6136148. DOI: 10.1016/j.jhep.2009.09.001. View

13.

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

14.

Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. DOI: 10.1007/BF00280883. View

15.

Brunt E, Janney C, Di Bisceglie A, Neuschwander-Tetri B, Bacon B . Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999; 94(9):2467-74. DOI: 10.1111/j.1572-0241.1999.01377.x. View

16.

Kleiner D, Brunt E, Van Natta M, Behling C, Contos M, Cummings O . Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41(6):1313-21. DOI: 10.1002/hep.20701. View

17.

Gutierrez-Repiso C, Garrido-Sanchez L, Alcaide-Torres J, Cornejo-Pareja I, Ocana-Wilhelmi L, Garcia-Fuentes E . Predictive Role of Gut Microbiota in Weight Loss Achievement after Bariatric Surgery. J Am Coll Surg. 2022; 234(5):861-871. DOI: 10.1097/XCS.0000000000000145. View

18.

Callahan B, McMurdie P, Rosen M, Han A, Johnson A, Holmes S . DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016; 13(7):581-3. PMC: 4927377. DOI: 10.1038/nmeth.3869. View

19.

Dhariwal A, Chong J, Habib S, King I, Agellon L, Xia J . MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res. 2017; 45(W1):W180-W188. PMC: 5570177. DOI: 10.1093/nar/gkx295. View

20.

Parks D, Tyson G, Hugenholtz P, Beiko R . STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014; 30(21):3123-4. PMC: 4609014. DOI: 10.1093/bioinformatics/btu494. View